Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 35 (3) , 229-243
- https://doi.org/10.1016/0010-7824(87)90025-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The clinical usefulness of glycated hemoglobin in monitoring diabetes mellitus: a long-term study.Clinical Chemistry, 1987
- Fibrocystic breast disease: Pathophysiology, pathomorphology, clinical picture, and managementAmerican Journal of Obstetrics and Gynecology, 1986
- Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrelContraception, 1985
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Fibrinopeptide a plasma levels during low-estrogen oral contraceptive treatmentContraception, 1984
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972